Connective Therapeutics Inc. (CNCT), Palo Alto, Calif. Product: Gamma interferon Indication: Keloids Status: CNCT began Phase II trials in keloids, fibrotic growths that result from excessive collagen formation in the skin during healing. The placebo-controlled,...
Connective Therapeutics Inc. (CNCT), Palo Alto, Calif. Product: Therapeutic vaccine targeted to T cell receptors Indication: Multiple sclerosis Status: CNCT began Phase I/II testing of a T cell receptor vaccine designed to elicit a heightened...
Connective Therapeutics Inc. (CNCT), Palo Alto, Calif. Product: Gamma interferon Indication: Keloids Status: CNCT began Phase II trials in keloids, fibrotic growths that result from excessive collagen formation in the skin during healing. The placebo-controlled,...
Connective Therapeutics Inc. (CNCT), Palo Alto, Calif. Product: Therapeutic vaccine targeted to T cell receptors Indication: Multiple sclerosis Status: CNCT began Phase I/II testing of a T cell receptor vaccine designed to elicit a heightened...